Pura Vida Investments, LLC Clovis Oncology, Inc. Call Options Transaction History

Pura Vida Investments, LLC

1 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $672 - $998	16 New	16 $1,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.